• Chad A Newton, Justin M Oldham, Carolyn Applegate, Nikkola Carmichael, Karen Powell, Dan Dilling, Shelley L Schmidt, Mary Beth Scholand, Mary Armanios, Christine Kim Garcia, Jonathan A Kropski, Janet Talbert, and Pulmonary Fibrosis Foundation Genetic Testing Work Group.
• Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
• Chest. 2022 Aug 1; 162 (2): 394405394-405.

AbstractPatients with familial pulmonary fibrosis represent a subset of patients with pulmonary fibrosis in whom inherited gene variation predisposes them to disease development. In the appropriate setting, genetic testing allows for personalized assessment of disease, recognition of clinically relevant extrapulmonary manifestations, and assessing susceptibility in unaffected relatives. However currently, the use of genetic testing is inconsistent, partly because of the lack of guidance regarding high-yield scenarios in which the results of genetic testing can inform clinical decision-making. To address this, the Pulmonary Fibrosis Foundation commissioned a genetic testing work group comprising pulmonologists, geneticists, and genetic counselors from the United States to provide guidance on genetic testing in patients with pulmonary fibrosis. This CHEST special feature presents a concise review of these proceedings and reviews pulmonary fibrosis susceptibility, clinically available genetic testing methods, and clinical scenarios in which genetic testing should be considered.Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

22 keywords...

hide…